Horiba Unveils Yumivet Vet Brand and VH2500 Analyser

Horiba has launched Yumivet, a new veterinary diagnostics brand, alongside its first product under the range: the Yumivet VH2500 haematology analyser designed for multi-species use in general practice. Announced on 8 July 2026, the launch extends Horiba’s move deeper into the companion animal and equine diagnostics market at a time of steady structural growth across veterinary in-clinic point-of-care testing. The VH2500 delivers results in around 30 seconds per test.

The VH2500 delivers a full haematology workup across 57 parameters, including complete blood count with nine-part differential, reticulocyte analysis, and dual platelet measurement methods, with a touchscreen interface and results in approximately 30 seconds per test. It supports cats, dogs and horses through pre-configured species profiles that cover advanced cell differentiation and reticulocyte counts, with automatic species selection or manual switching, and customisation options for practices with atypical caseloads. Both open tube and continuous sample loading are supported, giving practices flexibility across low-throughput and high-throughput workflows.

The VH2500 is designed to sit within a broader Horiba veterinary automation ecosystem, with integration into the Yumivet SPS slide maker and stainer, the Yumizen T6000 track system and Yumizen P8000 middleware. That integration positions the launch as more than a single-analyser move: Horiba is signalling a deliberate expansion of its veterinary diagnostics portfolio into a lightly consolidated segment currently dominated by IDEXX and Zoetis-owned VetScan. The Yumivet brand identity itself gives Horiba a dedicated positioning line for veterinary customers, separating the strategy from its existing human diagnostics business.

The commercial signal is Horiba positioning for a slice of the growing in-clinic veterinary diagnostics market, where consumables-led revenue models and platform-based cross-selling have generated some of the strongest margins in the animal health category. Expect the Yumivet brand to underpin further product introductions across chemistry, immunoassay and urinalysis over the next 24 months. IDEXX and VetScan should expect increased pricing scrutiny in the meantime.

For the latest updates and in-depth insights into the world of Animal Health, including breakthrough treatments, industry trends, and regulatory news, contact Albert Baines today!